FIM
AVXL icon

Fernwood Investment Management’s Anavex Life Sciences AVXL Stock Holding History

Fernwood Investment Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,000
Closed -$15.3K – 233
2024
Q1 		$15.3K Buy
+3,000
New +$16.9K ﹤0.01% 490

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fernwood Investment Management's AVXL Position: Q2 2024 in Review

Fernwood Investment Management sold out of Anavex Life Sciences (AVXL) in Q2 2024, closing a stake of 3,000 shares — an estimated $15.3K sold.

Fernwood Investment Management first reported a position in AVXL in Q1 2024 and held it in 1 quarter. The position peaked at $15.3K in Q1 2024. 140 funds tracked by Wall St. Rank hold AVXL as of Q2 2024.

  • Fernwood Investment Management reported no remaining Anavex Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Fernwood Investment Management sold 3,000 Anavex Life Sciences shares in Q2 2024, an estimated $15.3K.
  • Fernwood Investment Management first reported a position in Anavex Life Sciences in Q1 2024 and held it in 1 quarter.
  • Fernwood Investment Management's Anavex Life Sciences position peaked at $15.3K in Q1 2024.
  • 140 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2024.

Based on Fernwood Investment Management's 13F filing for Q2 2024, filed 31 Jul 2024.